Commentary: Abortion pills in pharmacies are the future. But the FDA should do more to expand access
On Jan. 3, the U.S. Food and Drug Administration took a first step toward making abortion pills available at retail pharmacies. It released new rules outlining how both bricks-and-mortar and mail-order pharmacies can get certified to dispense mifepristone, the first pill in a medication abortion. But the agency also left in place unnecessary restrictions, showing how far we have to go in offering access.
As a public health researcher and abortion safety expert, I welcome efforts to make abortion pills more easily
